Skip to content
Screener

Pacira BioSciences, Inc. PCRX Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$45K-83.0%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$997.34M-14.0%
Enterprise value$1.26B+4.9%
P/E194.1×
P/S1.4×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028871
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Amortization of debt issuance costs and debt discount577867
Stock-based compensation13,53914,553
Changes in contingent consideration(2,277)(2,675)
Net accretion of discount on available-for-sale investments(570)(1,910)
Other net gains(5,887)
Changes in operating assets and liabilities:
Accounts receivable, net(1,567)8,559
Inventories, net2,491(8,472)

Item 1. FINANCIAL STATEMENTS (Unaudited)

FAQ

What is Pacira BioSciences, Inc.'s accretion (amortization) of discounts and premiums, investments?
Pacira BioSciences, Inc. (PCRX) reported accretion (amortization) of discounts and premiums, investments of $570K in Q1 2026.
How has Pacira BioSciences, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
Pacira BioSciences, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 70.2% year-over-year, from $1.91M to $570K.
What does accretion (amortization) of discounts and premiums, investments mean?
Captures the non-cash adjustment to the carrying value of investment securities resulting from the amortization of premiums or accretion of discounts. This ensures that the interest income recognized on the income statement aligns with the effective interest method over the life of the investment.

Ask your AI about Pacira BioSciences, Inc.'s accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude